News
The FTSE 100 tumbled 2.92 percent on Wednesday, shedding 231.05 points to close at 7,679.48 points as U.S. President Donald Trump's sweeping tariff plan officially came into effect, sending shockwaves ...
Ministers must treat medicines supplies as a ‘defence’ issue as it faces ‘hostile activity’ over the brewing trade war ...
Zantac went on sale in the UK in 1981. But in 2019, GSK withdrew it in the UK and US over fears that the ingredient ...
Manila International Container Terminal has expanded its coverage in Asia with the arrival of a container service traversing three Asian countries and three Philippine ports.
Highlighted with 90 tables and 69 figures, this 168-page report ?Asia Pacific Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares ...
A GSK logo is seen on the side of an office building in Poznan, Poland. 33,658 people played the daily Crossword recently. Can you solve it faster than others?33,658 people played the daily ...
GSK plc GSK announced that the FDA has approved its oral antibiotic gepotidacin for treating uncomplicated urinary tract infections (uUTIs) in female adults and adolescents. A commercial launch ...
GSK plans the therapy’s commercial launch in the US for the second half of 2025. Credit: MAXSHOT.PL/Shutterstock. The US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene ...
LONDON (Reuters) -GSK (GSK.L) said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its best-selling shingles vaccine lowers the risk of dementia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results